Board Meeting16 Jul 2026, 04:40 pm
Mankind Pharma Board Meeting on July 30, 2026 for Q1 FY27 Results
AI Summary
Mankind Pharma Ltd has announced that its Board of Directors will convene on July 30, 2026. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. Additionally, the company has informed that the trading window for its securities will remain closed until August 1, 2026, in line with SEBI regulations and the company's code of conduct for preventing insider trading. This notice is also available on the company's website.
Key Highlights
- Board meeting scheduled for July 30, 2026.
- To approve unaudited Q1 FY27 financial results.
- Trading window closure extended until August 1, 2026.
- Notice complies with SEBI Listing Regulations.
Price Impact
More from MANKIND